Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

Clinical trial NCT01992549 · COMPLETED

Trial details

NCT number: NCT01992549
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2014-04-01
Primary completion: 2018-12-27
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.